Linked Life Data

11431240

Source:http://linkedlifedata.com/resource/pubmed/id/11431240

Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:11431240rdf:typepubmed:Citationlld:pubmed
pubmed-article:11431240lifeskim:mentionsumls-concept:C0087111lld:lifeskim
pubmed-article:11431240lifeskim:mentionsumls-concept:C0085631lld:lifeskim
pubmed-article:11431240lifeskim:mentionsumls-concept:C0036341lld:lifeskim
pubmed-article:11431240lifeskim:mentionsumls-concept:C0018546lld:lifeskim
pubmed-article:11431240lifeskim:mentionsumls-concept:C0171023lld:lifeskim
pubmed-article:11431240lifeskim:mentionsumls-concept:C0205178lld:lifeskim
pubmed-article:11431240lifeskim:mentionsumls-concept:C1707455lld:lifeskim
pubmed-article:11431240lifeskim:mentionsumls-concept:C0442117lld:lifeskim
pubmed-article:11431240pubmed:issue7lld:pubmed
pubmed-article:11431240pubmed:dateCreated2001-6-29lld:pubmed
pubmed-article:11431240pubmed:abstractTextThe authors evaluated the comparative efficacy and safety of intramuscular olanzapine, intramuscular haloperidol, and intramuscular placebo for the treatment of acute agitation in schizophrenia.lld:pubmed
pubmed-article:11431240pubmed:languageenglld:pubmed
pubmed-article:11431240pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:11431240pubmed:citationSubsetAIMlld:pubmed
pubmed-article:11431240pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:11431240pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:11431240pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:11431240pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:11431240pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:11431240pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:11431240pubmed:statusMEDLINElld:pubmed
pubmed-article:11431240pubmed:monthJullld:pubmed
pubmed-article:11431240pubmed:issn0002-953Xlld:pubmed
pubmed-article:11431240pubmed:authorpubmed-author:WrightPPlld:pubmed
pubmed-article:11431240pubmed:authorpubmed-author:BradleyPPlld:pubmed
pubmed-article:11431240pubmed:authorpubmed-author:FerchlandIIlld:pubmed
pubmed-article:11431240pubmed:authorpubmed-author:SaundersJ CJClld:pubmed
pubmed-article:11431240pubmed:authorpubmed-author:KruegerJJlld:pubmed
pubmed-article:11431240pubmed:authorpubmed-author:BernardiCClld:pubmed
pubmed-article:11431240pubmed:authorpubmed-author:SanLLlld:pubmed
pubmed-article:11431240pubmed:authorpubmed-author:BreierAAlld:pubmed
pubmed-article:11431240pubmed:authorpubmed-author:AlakaK JKJlld:pubmed
pubmed-article:11431240pubmed:authorpubmed-author:MeehanKKlld:pubmed
pubmed-article:11431240pubmed:authorpubmed-author:BirkettMMlld:pubmed
pubmed-article:11431240pubmed:authorpubmed-author:ReinsteinMMlld:pubmed
pubmed-article:11431240pubmed:authorpubmed-author:DavidS RSRlld:pubmed
pubmed-article:11431240pubmed:issnTypePrintlld:pubmed
pubmed-article:11431240pubmed:volume158lld:pubmed
pubmed-article:11431240pubmed:ownerNLMlld:pubmed
pubmed-article:11431240pubmed:authorsCompleteYlld:pubmed
pubmed-article:11431240pubmed:pagination1149-51lld:pubmed
pubmed-article:11431240pubmed:dateRevised2008-11-21lld:pubmed
pubmed-article:11431240pubmed:meshHeadingpubmed-meshheading:11431240...lld:pubmed
pubmed-article:11431240pubmed:meshHeadingpubmed-meshheading:11431240...lld:pubmed
pubmed-article:11431240pubmed:meshHeadingpubmed-meshheading:11431240...lld:pubmed
pubmed-article:11431240pubmed:meshHeadingpubmed-meshheading:11431240...lld:pubmed
pubmed-article:11431240pubmed:meshHeadingpubmed-meshheading:11431240...lld:pubmed
pubmed-article:11431240pubmed:meshHeadingpubmed-meshheading:11431240...lld:pubmed
pubmed-article:11431240pubmed:meshHeadingpubmed-meshheading:11431240...lld:pubmed
pubmed-article:11431240pubmed:meshHeadingpubmed-meshheading:11431240...lld:pubmed
pubmed-article:11431240pubmed:meshHeadingpubmed-meshheading:11431240...lld:pubmed
pubmed-article:11431240pubmed:meshHeadingpubmed-meshheading:11431240...lld:pubmed
pubmed-article:11431240pubmed:meshHeadingpubmed-meshheading:11431240...lld:pubmed
pubmed-article:11431240pubmed:meshHeadingpubmed-meshheading:11431240...lld:pubmed
pubmed-article:11431240pubmed:meshHeadingpubmed-meshheading:11431240...lld:pubmed
pubmed-article:11431240pubmed:meshHeadingpubmed-meshheading:11431240...lld:pubmed
pubmed-article:11431240pubmed:meshHeadingpubmed-meshheading:11431240...lld:pubmed
pubmed-article:11431240pubmed:meshHeadingpubmed-meshheading:11431240...lld:pubmed
pubmed-article:11431240pubmed:meshHeadingpubmed-meshheading:11431240...lld:pubmed
pubmed-article:11431240pubmed:meshHeadingpubmed-meshheading:11431240...lld:pubmed
pubmed-article:11431240pubmed:meshHeadingpubmed-meshheading:11431240...lld:pubmed
pubmed-article:11431240pubmed:meshHeadingpubmed-meshheading:11431240...lld:pubmed
pubmed-article:11431240pubmed:year2001lld:pubmed
pubmed-article:11431240pubmed:articleTitleDouble-blind, placebo-controlled comparison of intramuscular olanzapine and intramuscular haloperidol in the treatment of acute agitation in schizophrenia.lld:pubmed
pubmed-article:11431240pubmed:affiliationLilly Research Centre, Eli Lilly Company, Surrey, UK.lld:pubmed
pubmed-article:11431240pubmed:publicationTypeJournal Articlelld:pubmed
pubmed-article:11431240pubmed:publicationTypeClinical Triallld:pubmed
pubmed-article:11431240pubmed:publicationTypeComparative Studylld:pubmed
pubmed-article:11431240pubmed:publicationTypeRandomized Controlled Triallld:pubmed
pubmed-article:11431240pubmed:publicationTypeResearch Support, Non-U.S. Gov'tlld:pubmed
pubmed-article:11431240pubmed:publicationTypeMulticenter Studylld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:11431240lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:11431240lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:11431240lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:11431240lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:11431240lld:pubmed